There was an overall decrease in influenza vaccine uptake among United States adults from 2020 to 2024, according to study findings.

Earlier this summer the FDA asked Moderna for more efficacy data on its flu vaccine before it could review an mRNA-based ...

The COVID booster currently available is based on the JN.1 subvariant. Nimbus is a direct descendant of JN.1 – as is another ...

Study reveals primary cause of obesity — and it's not lack of exercise Moment CNN contributor’s young son crashes tense ...

A CDC advisory panel vote to recommend against use of seasonal influenza vaccines containing small amounts of thimerosal ...

While the new panel showed little conflict over the 2025-2026 seasonal flu vaccine recommendations, thimerosal fueled sharp reactions among members and outside observers.

Moderna’s new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial.

The CDC panel voted against an ingredient that the anti-vaccine movement has long targeted, while Arcadia was acquired by private equity firm Nordic Capital.